Clinical Trial Update: Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of vigabatrin for methamphetamine dependence was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

Sponsor: Catalyst Pharmaceuticals, Inc. | Conditions: Methamphetamine Dependence | Phase 2 | Status: TERMINATED | Results posted: 2020-12-09